Centessa Pharmaceuticals, LLC

Centessa Pharmaceuticals is a global biopharmaceutical company that uses an asset‑centric, portfolio model to accelerate the development of innovative medicines. With a patient‑centric mission, Centessa advances programs across sleep‑wake, neurological, neurodegenerative and psychiatric disorders — notably pursuing an Orexin Receptor 2 agonist program. The company combines specialized operating subsidiaries and centralized capabilities to move preclinical and clinical‑stage assets efficiently toward regulatory approval and commercialization. Centessa partners with academic and industry collaborators to translate promising science into transformative treatment options for patients.